Cargando…
Atypical hemolytic uremic syndrome in a patient with HIV treated with eculizumab: A case report
Thrombotic microangiopathy defines a group of pathologies characterized by microvascular dysfunction with the concurrence of microangiopathic hemolytic anemia, thrombocytopenia, and organ damage. It represents the most frequent microvascular manifestation of human immunodeficiency virus (HIV) infect...
Autores principales: | González, Danilo E.Trujillo, Misol, Dagoberto Duarte, Ordoñez, Nicolás Ariza, Zamora, Fabian Andres Salgado, Millan Prada, Henry A., Zuñiga R, Eduardo, Triviño, Alejandra Molano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867953/ https://www.ncbi.nlm.nih.gov/pubmed/36699966 http://dx.doi.org/10.1016/j.idcr.2023.e01692 |
Ejemplares similares
-
Critical appraisal of eculizumab for atypical hemolytic uremic syndrome
por: Palma, Lilian M Pereira, et al.
Publicado: (2016) -
Atypical hemolytic uremic syndrome and eculizumab therapy in children
por: Kim, Seong Heon, et al.
Publicado: (2018) -
Treatment of Atypical Hemolytic-Uremic Syndrome in the Era of Eculizumab
por: Ebrahem, Rawaa, et al.
Publicado: (2017) -
Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era
por: Gomes, Sara Madureira, et al.
Publicado: (2021) -
The Importance of Eculizumab in the Treatment of Atypical Hemolytic Uremic Syndrome
por: Santos, Mariana S, et al.
Publicado: (2022)